multiple testing, but eGFR was not available for 110 patients at 6 month postop.
INTRODUCTION AND OBJECTIVES:
As the prevalence of obesity dramatically increases worldwide, an increasing proportion of surgical candidates have an elevated Body Mass Index (BMI), with associated metabolic syndrome, diabetes, and hypertension. Yet whether these patients have worse perioperative outcomes is controversial. We examined whether obese patients had worse perioperative and postoperative renal function outcomes following robotic partial nephrectomies (RPN).
METHODS: We used a multi-institutional database to identify 1,770 patients with 2 kidneys that underwent RPN from 2008-2015 by six high volume surgeons. The association of BMI with perioperative outcomes and acute kidney injury at discharge (AKI, >25% reduction in eGFR), and change in eGFR per month (Range 3-24 months) post-RPN was evaluated. BMI was analyzed as a continuous and categorical variable using Center for Disease Control (CDC) groups. AKI at discharge was analyzed using multivariable logistic regression models and eGFR over time was evaluated using multivariable linear mixed effects models; both of which were adjusted for confounding variables including age, Charlsoncomorbidity index, tumor size, and the operating surgeon.
RESULTS: 45.2% (n[529) of patients were found to be obese, with a greater prevalence of hypertension and diabetes in patients with higher BMI (Table I) . Obese patients were more likely to have malignant tumors (p<.001) and trended towards having larger tumors (3.0cm vs 2.8cm; p[0.061). These patients required longer operative times, though equivalent warm ischemia times. Obesity was not correlated with complication rate (p>.05). On multivariable analysis, obesity (OR[1.81; p[0.031), male sex (OR[1.54; p[0.028) , and larger tumor size (OR[1.23; p<0.001) were associated with a significant increase in the likelihood of AKI. BMI above normal weight was not associated with greater eGFR decline per month from 3 to 24 months post-RPN.
CONCLUSIONS: Obese patients had more aggressive tumors, but did not demonstrate an increase in complications. Robotic Partial Nephrectomy appears to be an equally safe operative option for patients regardless of BMI.
Source of Funding: none

MP31-12 THE ALBUMIN-CREATININE RATIO AND KIDNEY FUNCTION OUTCOMES AFTER NEPHRECTOMY
Andrew Sun*, Stanford, CA; I-Chun Thomas, Palo Alto, CA; Calyani Ganesan, Alan Pao, Todd Wagner, James Brooks, Glenn Chertow, John Leppert, Stanford, CA INTRODUCTION AND OBJECTIVES: Patients are at risk of developing chronic kidney disease (CKD) after radical and partial nephrectomy. Severity of albuminuria is associated with CKD progression in patients with medical CKD, but it is unknown if quantitative assessment of albuminuria is associated with outcomes following nephrectomy. We assessed if the urine albumin/creatinine ratio (UACR) is associated with progressive CKD after nephrectomy.
METHODS: We identified patients who underwent nephrectomy from 2004 -2014 within the Veterans Health Administration, had a UACR measured in the 12 months before surgery, and a preoperative estimated glomerular filtration rate (eGFR) !30 mL/min/1.73 m2. We fit multivariable regression models to determine if the UACR was associated with development of stage 4 CKD. We performed a parallel analysis assessing development of stage 3B CKD among patients with normal or near-normal preoperative kidney function (eGFR !60 mL/ min/1.73 m2). Last, we examined overall survival.
RESULTS: In this cohort of 1930 patients, 658 (34.1%) and 157 (8.1%) had moderate or severe albuminuria, respectively. Albuminuria severity was associated with progressive CKD after radical (moderate albuminuria HR 1.75, 95% CI 1.41-2.17; severe albuminuria HR 2.28, 95% CI 1.66-3.13) and partial nephrectomy (moderate albuminuria HR 1.82, 95% CI 1.22-2.70; severe albuminuria HR 3.68, 95% CI 2.24-6.05) ( Table 1) . A similar association was seen with overall survival.
CONCLUSIONS: In patients undergoing nephrectomy, assessing the severity of albuminuria via the UACR can help stratify the risk of progressive CKD and help identify patients who would benefit from partial nephrectomy and medical optimization before surgery.
